Prospective assessment of the frequency of and risk factors for bleeding events in patients treated with cefazolin
ConclusionsBleeding events associated with cefazolin treatment are frequent. Close clinical monitoring should be performed for patients treated for endocarditis and/or receiving vitamin K antagonists. Hemostasis work-up could be restricted to these patients.
Source: Infection - Category: Infectious Diseases Source Type: research
More News: Bleeding | Endocarditis | Infectious Diseases | Intensive Care | Study | Thrombosis | Vitamin K | Vitamins